We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Noise, exhaust emissions, engine malfunction indicator lamp (MIL) (sometimes called an engine management light or 'EML'), and fluid leak rules and inspection for car and passenger vehicle MOT tests.
Qualasept Ltd t/a Bath ASU is recalling a specific batch of Irinotecan 200mg/260mL in sodium chloride 0.9% w/v intravenous infusion and specific batches of Infliximab (Remsima) Intravenous infusion in Sodium Chloride 0.9%w/v due to risks of reduced product quality.
Partnership underpinned by UK Fusion Materials Roadmap to gain insights on existing materials and to develop new ones for future fusion powerplants.
The Sawtooth Effect examines the patterns seen in student exam performance when assessments are reformed.
Technique provided by LLW Repository Ltd is paying off at Magnox Harwell, ensuring clean pipework is recycled into the metal market
The government has today published research into the motivations for carrying and using acid and other corrosives as a weapon.
First published during the 2019 to 2022 Johnson Conservative government
Upper Tribunal Tax and Chancery decision of Judge Jonathan Richards and Judge Guy Brannan on 24 June 2021
Febuxostat must be stopped immediately if hypersensitivity occurs and must not be re-started in patients who have ever developed a hypersensitivity reaction to febuxostat.
Caduceus Pharma Ltd., Pemetrexed 25mg/ml Concentrate for solution for Infusion: caution in use after particulates identified in a small number of vials (EL (16)A/09)
OECD paper on how to characterise hydrocarbons in mixtures
With the exception of medicines containing zidovudine, stavudine, or didanosine, product information will no longer include warnings on fat redistribution or lactic acidosis.
All patients with cancer should have a dental check-up before bisphosphonate treatment.
The UK National Screening Committee upheld its recommendation against screening programme for bladder cancer, following a review.
Pfizer UK Limited is recalling batches as routine stability testing has identified that levels of a known impurity, 10-oxo-docetaxel, may exceed the acceptable level at end of shelf-life.
Decision outcome on an application under section 72 for the revocation of Patent EP (UK) 0153580.
The Home Office has held a joint event with the NPCC to bring together law enforcement, government, retailers and medical experts to tackle the issue of ‘acid attacks’.
First published during the 2016 to 2019 May Conservative government
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).